Literature DB >> 21832206

Renal oxidative stress, oxygenation, and hypertension.

Fredrik Palm1, Lina Nordquist.   

Abstract

Hypertension is closely associated with progressive kidney dysfunction, manifested as glomerulosclerosis, interstitial fibrosis, proteinuria, and eventually declining glomerular filtration. The postulated mechanism for development of glomerulosclerosis is barotrauma caused by increased capillary pressure, but the reason for development of interstitial fibrosis and the subsequently reduced kidney function is less clear. However, it has been hypothesized that tissue hypoxia induces fibrogenesis and progressive renal failure. This is very interesting, since recent reports highlight several different mechanisms resulting in altered oxygen handling and availability in the hypertensive kidney. Such mechanisms include decreased renal blood flow due to increased vascular tone induced by ANG II that limits oxygen delivery and increases oxidative stress, resulting in increased mitochondrial oxygen usage, increased oxygen usage for tubular electrolyte transport, and shunting of oxygen from arterial to venous blood in preglomerular vessels. It has been shown in several studies that interventions to prevent oxidative stress and to restore kidney tissue oxygenation prevent progression of kidney dysfunction. Furthermore, inhibition of ANG II activity, by either blocking ANG II type 1 receptors or angiotensin-converting enzyme, or by preventing oxidative stress by administration of antioxidants also results in improved blood pressure control. Therefore, it seems likely that tissue hypoxia in the hypertensive kidney contributes to progression of kidney damage, and perhaps also persistence the high blood pressure.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21832206      PMCID: PMC3213938          DOI: 10.1152/ajpregu.00720.2010

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  132 in total

1.  Therapeutic targeting of mitochondrial superoxide in hypertension.

Authors:  Anna E Dikalova; Alfiya T Bikineyeva; Klaudia Budzyn; Rafal R Nazarewicz; Louise McCann; William Lewis; David G Harrison; Sergey I Dikalov
Journal:  Circ Res       Date:  2010-05-06       Impact factor: 17.367

2.  NADPH-dependent microsomal lipid peroxidation and the problem of pathological action at a distance. New data on induction of red cell damage.

Authors:  M K Roders; E A Glende; R O Recknagel
Journal:  Biochem Pharmacol       Date:  1978-02-15       Impact factor: 5.858

3.  Angiotensin II augments medullary hypoxia and predisposes to acute renal failure.

Authors:  M Brezis; Z Greenfeld; A Shina; S Rosen
Journal:  Eur J Clin Invest       Date:  1990-04       Impact factor: 4.686

4.  Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis.

Authors:  R A Risdon; J C Sloper; H E De Wardener
Journal:  Lancet       Date:  1968-08-17       Impact factor: 79.321

Review 5.  Essential hypertension, progressive renal disease, and uric acid: a pathogenetic link?

Authors:  Richard J Johnson; Mark S Segal; Titte Srinivas; Ahsan Ejaz; Wei Mu; Carlos Roncal; Laura G Sánchez-Lozada; Michael Gersch; Bernardo Rodriguez-Iturbe; Duk-Hee Kang; Jaime Herrera Acosta
Journal:  J Am Soc Nephrol       Date:  2005-04-20       Impact factor: 10.121

6.  Superoxide activates mitochondrial uncoupling proteins.

Authors:  Karim S Echtay; Damien Roussel; Julie St-Pierre; Mika B Jekabsons; Susana Cadenas; Jeff A Stuart; James A Harper; Stephen J Roebuck; Alastair Morrison; Susan Pickering; John C Clapham; Martin D Brand
Journal:  Nature       Date:  2002-01-03       Impact factor: 49.962

7.  Evidence that renal arterial-venous oxygen shunting contributes to dynamic regulation of renal oxygenation.

Authors:  Chai-Ling Leong; Warwick P Anderson; Paul M O'Connor; Roger G Evans
Journal:  Am J Physiol Renal Physiol       Date:  2007-02-27

8.  Upregulation of autocrine-paracrine renin-angiotensin systems in chronic renovascular hypertension.

Authors:  Javid Sadjadi; Krishna Puttaparthi; M Burress Welborn; Thomas E Rogers; Orson Moe; G Patrick Clagett; Richard H Turnage; Moshe Levi; J Gregory Modrall
Journal:  J Vasc Surg       Date:  2002-08       Impact factor: 4.268

9.  Imbalance of T-cell subsets in angiotensin II-infused hypertensive rats with kidney injury.

Authors:  Jing Shao; Masaomi Nangaku; Toshio Miyata; Reiko Inagi; Koei Yamada; Kiyoshi Kurokawa; Toshiro Fujita
Journal:  Hypertension       Date:  2003-05-27       Impact factor: 10.190

10.  Role of nitric oxide in the control of renal oxygen consumption and the regulation of chemical work in the kidney.

Authors:  S K Laycock; T Vogel; P R Forfia; J Tuzman; X Xu; M Ochoa; C I Thompson; A Nasjletti; T H Hintze
Journal:  Circ Res       Date:  1998-06-29       Impact factor: 17.367

View more
  31 in total

1.  Mitochondrial proteomic analysis reveals deficiencies in oxygen utilization in medullary thick ascending limb of Henle in the Dahl salt-sensitive rat.

Authors:  Nadezhda N Zheleznova; Chun Yang; Robert P Ryan; Brian D Halligan; Mingyu Liang; Andrew S Greene; Allen W Cowley
Journal:  Physiol Genomics       Date:  2012-07-17       Impact factor: 3.107

2.  P2Y12 Receptor Localizes in the Renal Collecting Duct and Its Blockade Augments Arginine Vasopressin Action and Alleviates Nephrogenic Diabetes Insipidus.

Authors:  Yue Zhang; Janos Peti-Peterdi; Christa E Müller; Noel G Carlson; Younis Baqi; David L Strasburg; Kristina M Heiney; Karie Villanueva; Donald E Kohan; Bellamkonda K Kishore
Journal:  J Am Soc Nephrol       Date:  2015-04-08       Impact factor: 10.121

3.  Activation of hypoxia-inducible factors prevents diabetic nephropathy.

Authors:  Lina Nordquist; Malou Friederich-Persson; Angelica Fasching; Per Liss; Kumi Shoji; Masaomi Nangaku; Peter Hansell; Fredrik Palm
Journal:  J Am Soc Nephrol       Date:  2014-09-02       Impact factor: 10.121

4.  NADPH oxidase inhibition reduces tubular sodium transport and improves kidney oxygenation in diabetes.

Authors:  Patrik Persson; Peter Hansell; Fredrik Palm
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-05-02       Impact factor: 3.619

5.  Chlorella pyrenoidosa ameliorated L-NAME-induced hypertension and cardiorenal remodeling in rats.

Authors:  Su-Ching Yang; Hsin-Yi Yang; Yi-Ching Yang; Hsiang-Chi Peng; Pei-Yin Ho
Journal:  Eur J Nutr       Date:  2012-05-03       Impact factor: 5.614

Review 6.  Relationships between vascular oxygen sensing mechanisms and hypertensive disease processes.

Authors:  Sachin A Gupte; Michael S Wolin
Journal:  Hypertension       Date:  2012-06-18       Impact factor: 10.190

Review 7.  Mitochondria-Associated Endoplasmic Reticulum Membranes (MAMs) and Their Prospective Roles in Kidney Disease.

Authors:  Peng Gao; Wenxia Yang; Lin Sun
Journal:  Oxid Med Cell Longev       Date:  2020-09-03       Impact factor: 6.543

8.  Endoplasmic reticulum stress as a pro-fibrotic stimulus.

Authors:  Harikrishna Tanjore; William E Lawson; Timothy S Blackwell
Journal:  Biochim Biophys Acta       Date:  2012-11-28

Review 9.  Mitochondrial dysfunction and mitophagy: the beginning and end to diabetic nephropathy?

Authors:  G C Higgins; M T Coughlan
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

10.  Renoprotective effect of combined inhibition of angiotensin-converting enzyme and histone deacetylase.

Authors:  Yifei Zhong; Edward Y Chen; Ruijie Liu; Peter Y Chuang; Sandeep K Mallipattu; Christopher M Tan; Neil R Clark; Yueyi Deng; Paul E Klotman; Avi Ma'ayan; John Cijiang He
Journal:  J Am Soc Nephrol       Date:  2013-04-04       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.